The goal of our laboratory is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma, three paediatric solid tumours in which high-risk patient ...

Our group's aim is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma. The goal of our laboratory is to improve the treatment and survival of ...

"Search" is our twice-yearly newsletter to supporters. In our latest edition of Spring Search issue, we look at the latest research news including how our scientists are developing improved breast ...

Scientists at The Institute of Cancer Research, London, have identified a gene that affects how ovarian clear cell carcinoma (OCCC) could respond to a new class of drug called ATR inhibitors. In ...

The Breast Cancer Now Toby Robins Research Centre at the ICR receives funding from the charity Breast Cancer Now, and was opened in 1999 by Breast Cancer Now's Patron, HRH The Prince of Wales. The ...

Dr Gabriela Kramer-Marek’s group uses cutting-edge biomedical imaging techniques to gain information about the way particular genes drive cancer progression. Our group’s long-term goal is to develop ...

New research has provided insight into the biological mechanisms that may contribute to poor outcomes in certain cases of neuroblastoma – a cancer that develops in nerve tissue and primarily affects ...

The ICR takes part in a range of public events, including local science festivals, events at museums and community events where we share knowledge and ideas about our research with the public. As part ...